DONNA E FRIEDLANDER
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant ROCHESTER, NY NPI 1922017714
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant NY Lexicon Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$907.99
- Category: General Payments
- Program years: PY2021–2024
- Record count: 50
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $272.04 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $272.04 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lexicon Pharmaceuticals, Inc. | $115.28 | 1 |
| ATRICURE, INC. | $63.54 | 2 |
| PFIZER INC. | $32.08 | 2 |
| Amgen Inc. | $31.93 | 2 |
| Acerta Pharma LLC | $29.21 | 2 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1081717934 | Lexicon Pharmaceuticals, Inc. | $115.28 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104433551 | AstraZeneca Pharmaceuticals LP | $15.59 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104784020 | AstraZeneca Pharmaceuticals LP | $13.62 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115636558 | Amgen Inc. | $13.10 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115636566 | Amgen Inc. | $18.83 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131229751 | PFIZER INC. | $16.78 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131383042 | PFIZER INC. | $15.30 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1132851517 | ATRICURE, INC. | $30.20 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1132889756 | ATRICURE, INC. | $33.34 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.